Genor Biopharma Holdings Limited carries a market capitalization of 944.32M, placing it among publicly traded companies globally.
| Market Cap | 944.32M |
| Enterprise Value | N/A |
Genor Biopharma Holdings Limited's stock has declined approximately -26.22951% over the past 52 weeks. The 50-day moving average sits at 2.21, while the 200-day moving average is 2.56.
| Beta (5Y) | N/A |
| 52-Week Price Change | -26.22951% |
| 50-Day Moving Average | 2.21 |
| 200-Day Moving Average | 2.56 |
| Average Volume (20 Days) | N/A |